
Xylem fell 33.2% from $140.99 to $94.18, behind the S&P 500's +13.3%. Its worst day was Oct 27 (−14.2%), and its low came Oct 28 at $88.23.
Nov 17, 2025 – Nov 13, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Xylem closed at its highest level of the year, 3.6% above where the year started.
+0.9% · S&P 500 −0.1%
EPS of $1.42 beat the $1.41 estimate on $2.4B revenue (est. $2.4B); FY revenue guidance of $9.1B–$9.2B against the $9.3B consensus.
Story events cover the past 12 months · Times ET
−8.0% · S&P 500 −0.3%
EPS of $1.12 beat the $1.08 estimate on $2.1B revenue (est. $2.1B); FY revenue guidance of $9.2B–$9.3B against the $9.2B consensus.
−4.5% · S&P 500 −0.5%
EPS of $1.46 beat the $1.34 estimate on $2.3B revenue (est. $2.3B); Q3 revenue guidance of $2.3B against the $2.3B consensus.
+4.0% · S&P 500 +0.2%
Xylem shares fell 5.5%, while the S&P 500 fell 0.1%.
−5.5% · S&P 500 −0.1%
EPS of $1.44 missed the $1.45 estimate on $2.2B revenue (est. $2.3B); Q4 revenue guidance of $2.3B against the $2.4B consensus.
−14.2%, the year's worst day · S&P 500 +0.6%
Xylem shares rose 5.0%, while the S&P 500 rose 1.7%.
+5.0% · S&P 500 +1.7%
Where it ended: a close of $94.18 on Nov 13, 2026. Up next: Q4 2026 earnings on Feb 9, 2027 (EPS est. $1.42, revenue est. $2.3B).
As of the Nov 13, 2026 close
Replay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for XYL and SPY from Benzinga historical bars. Not investment advice.